Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05972850
Other study ID # IRB00094007
Secondary ID P30AG021332
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date March 19, 2024
Est. completion date July 1, 2025

Study information

Verified date April 2024
Source Wake Forest University Health Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This pilot study will assess the feasibility and generate preliminary efficacy data of a novel, synchronous, home-based exercise training program for rural older adults with cardiovascular disease (CVD) using Vivo, an online, live, small group fitness program developed for older adults. It uses individually tailored dual-tasked (i.e., cognitive-motor) exercises to improve strength, endurance, balance, and cognition and incorporates social engagement. Certified trainers deliver instruction and coaching through an interactive session (45 min, 2-3 times/week) delivered over 12 weeks. Vivo Heart adapts this unique program to meet the cardiac rehabilitation needs of older adults with CVD. The specific aims are to evaluate the feasibility, acceptability, and uptake of Vivo Heart (Aim 1) and obtain pre- and post-intervention measures of exercise capacity, strength, lower-extremity physical function, cognition, quality of life, stress, fatigability, physical activity, and aging biomarkers (Aim 2).


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 40
Est. completion date July 1, 2025
Est. primary completion date July 1, 2025
Accepts healthy volunteers No
Gender All
Age group 60 Years to 80 Years
Eligibility Inclusion Criteria: - 60 - 80 years - Lives in a rural area based on established urban-rural definitions (e.g., RUCA codes, RUCC, UIC) - A qualifying Cardio Vascular Disease (CVD) event or procedure - Cognitively unimpaired Telephone Interview for Cognitive Status (TICS-m =32) - No major depressive symptoms Patient Health Questionnaire (PHQ-8 <10) - Ambulatory and community-dwelling - Less than 150 min per week of moderate-to-intensive aerobic or resistance exercise in the past month - Medically cleared for exercise if event was within the last 6 months - Access to a tablet or computer and internet/Wi-Fi in defined exercise space - Able to provide own transportation to study visits - Not participating in a clinical trial - Willing to provide informed consent Exclusion Criteria: - <60 years or >80 years - Lives in non-rural area - No CVD or a qualifying event or procedure - Dementia or severe cognitive impairment (TICS-m <32) - Clinical depression (PHQ-8 =10) - Non-ambulatory, institutionalized, or requires walker - Regular aerobic or resistance exercise (including current participation in a cardiac rehab program) - Not medically cleared for exercise - Advanced kidney disease requiring dialysis or dialysis anticipated within 6 months - Insulin-dependent diabetes - Use of any supplemental oxygen for COPD - Significant impairment from a prior stroke - Progressive neurologic disease (Parkinson's, ALS, multiple sclerosis, Alzheimer's disease, dementia) - Severe arthritis, fracture, chronic injury, or other musculoskeletal disorder that prevents walking independently - Cancer (not including non-melanoma skin cancers) requiring treatment with the past year - Excessive alcohol consumption (>7/week alcoholic beverages for women and >14/week for men) in the past month - Joint replacement or other orthopedic surgery in past 12 months or planned in next 6 months - No computer, tablet or internet access - No access to transportation for travel to study visits - Current participation in a clinical trial - Inability or unwillingness to comply with the study requirements

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Vivo Heart
Vivo is an online, live, small group fitness program developed for older adults that uses individually tailored dual-tasked (i.e., cognitive-motor) exercises to improve strength, endurance, balance, and cognition and incorporates social engagement. Certified trainers deliver instruction and coaching through an interactive session for 45 min, 2-3 times/week.

Locations

Country Name City State
United States Wake Forest University Health Sciences Winston-Salem North Carolina

Sponsors (2)

Lead Sponsor Collaborator
Wake Forest University Health Sciences National Institute on Aging (NIA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other VO2 peak Change in VO2 peak Week 12
Other Montreal Cognitive Assessment (MoCA) Change in overall cognition (0-30) Week 12
Other Digit Symbol Coding (DSC) Change in processing speed, working memory, visuospatial processing, and attention (secs) Week 12
Other Timed Up and Go (TUG) Change in time to complete (secs) Week 12
Other Expanded Short Physical Performance Battery (eSPPB) Change in score (0-4) Week 12
Other The Four Square Step Test (FSST) Change in time to complete (secs) Week 12
Other 4-step Stair Climb Test (4SCT) Change in time to complete (secs) Week 12
Other Grip Strength Change in grip strength (kg) Week 12
Other Perceived Stress Scale (PSS) Change in score Week 12
Other Short Form-36 Health Survey (SF-36) Change in score Week 12
Other UCLA Loneliness Scale Change in score Week 12
Other Life Space Change in score Week 12
Other Pittsburgh Fatigability Scale (PFS) Change in score Week 12
Other Blood pressure Change in systolic and diastolic blood pressure (mmHg) Week 12
Other Heart rate Change in resting heart rate (bpm) Week 12
Primary Completion Rate Completion rate which will be determined by the percentage of enrolled participants who complete the study with =80% compliance. Week 12
Secondary Recruitment Rate Recruitment rate will be determined by the total number of enrolled participants divided by the number of months recruitment occurred. Year 1
Secondary Recruitment Yield Recruitment yield will be determined based on the number of participants randomized relative to the total number of volunteers screened Year 1
Secondary Compliance Rate Compliance will be determined based on adherence to the prescribed intervention. Compliance metrics will include attendance at the exercise sessions, health education classes, and dietary counseling sessions. Week 12
Secondary Retention Rate Retention will be determined by the percentage of enrolled participations who complete follow-up testing. Week 12
Secondary Satisfaction Survey Scores Acceptability will be assessed at the end of the study using a program satisfaction survey. Week 12
Secondary Continuation Rate Uptake will be determined by the number of participants who continue in the Vivo program after the study is over. Year 1
See also
  Status Clinical Trial Phase
Completed NCT02122198 - Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women N/A
Completed NCT02502812 - Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects Phase 1
Recruiting NCT04216342 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers Phase 1
Completed NCT03654313 - Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus Phase 1
Completed NCT03646656 - Heart Health Buddies: Peer Support to Decrease CVD Risk N/A
Completed NCT02081066 - Identification of CETP as a Marker of Atherosclerosis N/A
Completed NCT02147626 - Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia N/A
Not yet recruiting NCT06405880 - Pharmacist Case Finding and Intervention for Vascular Prevention Trial N/A
Recruiting NCT03095261 - Incentives in Cardiac Rehabilitation N/A
Not yet recruiting NCT02578355 - National Plaque Registry and Database N/A
Completed NCT02711878 - Healing Hearts and Mending Minds in Older Adults Living With HIV N/A
Completed NCT02868710 - Individual Variability to Aerobic Exercise Training N/A
Completed NCT02998918 - Effects of Short-term Curcumin and Multi-polyphenol Supplementation on the Anti-inflammatory Properties of HDL N/A
Completed NCT02589769 - Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons N/A
Recruiting NCT02885792 - Coronary Artery Disease in Patients Suffering From Schizophrenia N/A
Completed NCT02640859 - Investigation of Metabolic Risk in Korean Adults
Completed NCT02272946 - Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk Phase 2
Completed NCT02657382 - Mental Stress Ischemia: Biofeedback Study N/A
Completed NCT02652975 - Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium N/A
Recruiting NCT02265250 - Pilot Study-Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment